This Medtech Company Is Bringing "Precision" Medicine To Cardiovascular Diagnostics

Meesha Dogan, PhD, CEO, Co-Founder and Director of Cardio Diagnostics CDIO, was recently a guest on Benzinga's All-Access.

Cardio Diagnostics makes cardiovascular disease prevention and early detection more accessible, personalized and precise. Its proprietary AI platform called Genetic-Epigenetic Engine is designed to help healthcare professionals better detect and diagnose coronary heart disease and tailor treatment "precisely" to each patient.

Ms. Dogan spoke about the innovative approach and how her company is the only one doing it in the cardiovascular space.

Learn more here:

Featured photo by Ryan ‘O’ Niel on Unsplash.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.